Physician profile
Dima Teitelman
NPI 1548285497
$4,696.21
in general payments reported to CMS, 2019-2025
34 companies · $1,342 in 2025
The $1,342 reported for 2025 was more than what 76% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $173 · 2020: $118 · 2021: $341 · 2022: $369 · 2023: $1,126 · 2024: $1,228 · 2025: $1,342.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,596 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,595.58 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $737.16 | 2019-2025 | Varithena Administration Pack, Watchman Flx, Watchman Access System |
| Novartis Pharmaceuticals Corporation | $667.24 | 2020-2025 | |
| Medtronic, INC. | $538.55 | 2023-2025 | Cobalt Dr Mri Surescan, Aurora Ev-Icd Mri Surescan, Selectsecure |
| Astrazeneca Pharmaceuticals LP | $360.81 | 2024-2025 | Farxiga, Airsupra, Breztri |
| Lilly USA, LLC | $283.94 | 2020-2024 | Mounjaro, Zepbound |
| Actelion Pharmaceuticals US, INC. | $283.19 | 2024-2025 | Opsumit, Uptravi |
| Pfizer INC. | $153.43 | 2022-2025 | |
| Esperion Therapeutics, INC. | $136.48 | 2021 | |
| Exact Sciences Corporation | $136.14 | 2023-2025 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $133.19 | 2021-2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $127.05 | 2024-2025 | |
| Vivaquant INC, Dba Rhythm Express | $116.00 | 2025 | Rhythm Express |
| Amarin Pharma, INC. | $113.35 | 2019-2021 | |
| Amgen INC. | $90.55 | 2022-2025 | Repatha, Repatha |
| Scpharmaceuticals INC. | $80.22 | 2025 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $78.74 | 2022-2025 | Amvuttra |
| Abbott Laboratories | $67.97 | 2021-2024 | Aveir |
| Edwards Lifesciences Corporation | $65.52 | 2022-2025 | Sapien 3 Ultra Resilia |
| Kiniksa Pharmaceuticals International, Plc | $62.54 | 2024 | Arcalyst |
| Novo Nordisk INC | $57.62 | 2020-2023 | |
| Medicomp INC | $50.04 | 2025 | Telepatch Cardiac Monitor |
| Lexicon Pharmaceuticals, INC. | $49.26 | 2023-2024 | Inpefa |
| Cequr Corporation | $42.41 | 2024 | Cequr Simplicity |
| Kestra Medical Technology Services, INC. | $35.71 | 2023 | Assure Wcd |
| Bridgebio Pharma, INC. | $32.11 | 2025 | Attruby |
| Glaxosmithkline, LLC. | $26.04 | 2025 | Arexvy, Shingrix |
| E.R. Squibb & Sons, L.L.C. | $25.32 | 2024 | Camzyos |
| Intra-Sana Laboratories | $25.31 | 2024 | Reltone 200 Mg, Glycate, Reltone 400 Mg |
| Horizon Therapeutics Plc | $23.09 | 2022 | |
| Heartflow, INC. | $21.15 | 2025 | |
| Kiniksa Pharmaceuticals, LTD. | $21.03 | 2023 | Arcalyst |
| Janssen Pharmaceuticals, INC | $21.00 | 2022 | |
| Merck Sharp & Dohme LLC | $18.06 | 2023 | |
| Xeris Pharmaceuticals, INC. | $15.99 | 2023 | Keveyis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dima Teitelman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.